It
is a neurological disorder triggered as a result of brain`s failure to regulate
sleep-wake cycles. The patients suffering from this medical condition can
experience excessive sleep during day time and cataplexy. Hallucinations,
sleep-paralysis and Insomnia are some of the major symptoms of this disorder.
The
researchers have discovered that the narcolepsy patients have blood T cells
which react to a particular hyprocretin protein. T cells are an essential part
of immune system which fights against infection. It might be possible to treat
narcolepsy with an immune-suppressing therapy.
Bentham Science
Publishers is one of the remarkable STM publishers in the
world. CNS &Neurological Disorders - Drug Targets
aims to cover all the latest and outstanding developments on the medicinal
chemistry, pharmacology, molecular biology, genomics and biochemistry of
contemporary molecular targets involved in neurological and central nervous
system (CNS) disorders. This
journal publishes guest edited thematic issues written by leaders
in the field covering a range of current topics of CNS & neurological drug
targets. For further details, please visit:
http://www.benthamscience.com/cdtcnsnd/index.htm
No comments:
Post a Comment